Avoro Capital Advisors LLC Amicus Therapeutics, Inc. Transaction History
Avoro Capital Advisors LLC
- $5.48 Billion
- Q2 2025
A detailed history of Avoro Capital Advisors LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 18,000,000 shares of FOLD stock, worth $126 Million. This represents 1.88% of its overall portfolio holdings.
Number of Shares
18,000,000
Previous 20,500,000
12.2%
Holding current value
$126 Million
Previous $167 Million
38.34%
% of portfolio
1.88%
Previous 2.71%
Shares
25 transactions
Others Institutions Holding FOLD
# of Institutions
299Shares Held
332MCall Options Held
396KPut Options Held
246K-
Vanguard Group Inc Valley Forge, PA29.4MShares$205 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA29.1MShares$203 Million0.03% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$170 Million0.01% of portfolio
-
William Blair Investment Management, LLC Chicago, IL14.6MShares$102 Million0.24% of portfolio
-
Vestal Point Capital, LP New York, NY11.9MShares$83.1 Million3.59% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $1.96B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...